Prevalence and risk factors for metabolic dysfunction–associated steatotic liver disease in Sweden: Insights from the SCAPIS cohort
In Sweden, almost one in five middle-aged adults is affected by MASLD, with a quarter of cases at risk of advanced fibrosis. Male sex, obesity, T2DM, and hypertension are important predictors of the prevalence and severity of MASLD.
Authors
- Daniel P. Andersson (ORCID: https://orcid.org/0000-0003-4655-4837)
- Oumarou Nabi (ORCID: https://orcid.org/0000-0003-4903-9611)
- Tomas Jernberg
- Jonas Spaak
- Gunnar Engström
- Joel Kullberg
- G Bergstrom
- C J Ostgren
- H Hagstrom
- Anders Blomberg
Institutions
- Linköping University (SE)
- Uppsala University (SE)
- Karolinska University Hospital (SE)
- Uppsala University Hospital (SE)
- Lund University (SE)
- Danderyds sjukhus (SE)
- Karolinska Institutet (SE)
- Region Västra Götaland (SE)
- Glanrhyd Hospital (GB)
- Antaros Medical (Sweden) (SE)
- University of Gothenburg (SE)
- Umeå University (SE)
Publication Details
- Journal
- Journal of Internal Medicine
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1111/joim.70071
- Citations
- 1
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 31.52
Funders
- Karolinska Institutet
- Stockholms Läns Landsting
- Vetenskapsrådet
- Svenska Läkaresällskapet
- Center for Innovative Medicine